Table 5: Viral suppression among persons aged ≥13 years living with HIV, 17 US jurisdictionsa, 2012-2015

Characteristic Viral Suppression
2012 2013 2014 2015 Trend in 2012-2015
(N=440,375) (N=451,885) (N=464,461) (N=477,928) EAPC 95% CI P-value
No. (%) No. (%) No. (%) No. (%) Lower Upper
Sex
      Male 184,330 54.3 199,908 57.2 214,601 59.6 221,923 59.8 3.3 3.1 3.5 <.001
      Female 50,921 50.5 54,913 53.6 58,458 56.0 60,886 57.1 4.2 3.8 4.6 <.001
Race/Ethnicity
      Black/Afican American 80,058 46.6 87,808 49.9 94,951 52.3 99,078 52.9 4.3 4 4.6 <.001
      Hispanic/Latino 58,732 53.8 63,416 56.0 68,760 58.6 71,787 59.0 3.2 2.9 3.6 <.001
      White 80,078 60.9 85,921 64.1 90,356 66.4 92,223 66.4 3 2.7 3.3 <.001
      Other 16,383 59.3 17,676 62.3 18,992 64.8 19,721 65.7 3.5 2.8 4.2 <.001
Age group at diagnosis
      13-24 6,201 39.8 7,200 45.2 7,911 49.9 8,246 52.8 9.8 8.6 10.9 <.001
      25-34 28,504 45.8 32,115 50.1 35,666 53.3 38,058 54.5 5.9 5.4 6.4 <.001
      35-44 56,423 51.6 57,282 54.3 58,184 56.8 57,243 57.1 3.5 3.1 3.9 <.001
      45-54 88,692 56.5 94,059 59.0 98,182 61.0 98,479 61.0 2.7 2.4 3 <.001
      55+ 55,431 57.7 64,165 59.9 73,116 61.8 80,783 61.8 2.3 2 2.7 <.001
Stage at diagnosis
      HIV infection stage 3(AIDS) 61,281 56.1 65,045 58.4 68,374 60.4 69,991 60.6 2.7 2.3 3 <.001
      Not known to be HIV infection stage 3 173,970 52.5 189,776 55.7 204,685 58.3 212,818 58.7 3.8 3.6 4 <.001
Transmission Categoryc
      Male-to-male sexual contact 135,257 56.9 148,554 60.0 160,922 62.4 168,400 62.6 3.2 3 3.5 <.001
      Injection drug use 31,578 44.9 32,747 47.2 33,706 49.1 33,182 48.8 2.9 2.4 3.4 <.001
      Male-to-male sexual contact and injection drug use 15,331 53.7 16,017 56.5 16,769 59.3 16,652 59.0 3.3 2.6 4.1 <.001
      Heterosexual contactd 52,111 51.1 56,492 54.0 60,613 56.3 63,499 57.3 3.9 3.5 4.2 <.001
      Othere 974 52.3 1,011 54.7 1,050 57.2 1,076 58.2 3.7 0.9 6.6 .009
Total 235,251 53.4 254,821 56.4 273,059 58.8 282,809 59.2 3.5 3.3 3.7 <.001

Abbreviations: HIV= Human Immunodeficiency Virus, EAPC=Estimated Annual Percent Change. Note: The denominator for each characteristic for each year are not presented. aJurisdictions include California, District of Columbia, Hawaii, Iowa, Illinois, Indiana, Louisiana, Maryland, Michigan, Missouri, New Hampshire, New York, North Dakota, South Carolina, Texas, Utah, and West Virginia. bDefined as a viral load result of <200 copies/mL or, if the quantitative value was missing, a test interpretation value of “undetected”, at the time of the most recent viral load test during the outcome year. cData statistically adjusted to account for missing transmission categories. dHeterosexual contact with a person known to have, or to be at high risk for, HIV infection. eIncludes hemophilia, blood transfusion, perinatal exposure and risk factor not reported or not identified.

Back to Article